US Broker Ratings

REGENXBIO Inc. (RGNX) Stock Analysis: Unpacking the 263% Potential Upside

REGENXBIO Inc. (NASDAQ: RGNX) is capturing investor attention with a remarkable potential upside of 263.27%. This clinical-stage biotechnology firm is making waves in the healthcare sector,..

Beta Bionics, Inc. (BBNX) Stock Analysis: Potential Upside of 74% in the Innovative Medical Device Sector

Beta Bionics, Inc. (NASDAQ: BBNX), a notable player in the healthcare sector, is making significant strides in the medical devices industry. Based in Irvine, California, the..

Cronos Group Inc. (CRON) Stock Analysis: Evaluating a 9% Potential Upside in the Cannabis Sector

Cronos Group Inc. (NASDAQ: CRON), a prominent player in the cannabinoid sector, has been garnering attention from investors due to its significant revenue growth and potential..

Dianthus Therapeutics (DNTH) Stock Analysis: Exploring a Potential 172% Upside with Analyst Confidence

Dianthus Therapeutics, Inc. (DNTH), a burgeoning entity in the biotechnology sector, is catching the eyes of investors seeking to capitalize on its promising growth potential. With..

Auna SA (AUNA) Stock Analysis: Significant Upside Potential with Nearly 100% Growth Forecast

Auna SA (AUNA), a Luxembourg-based leader in the healthcare sector, operates an extensive network of hospitals and clinics across Mexico, Peru, and Colombia. With a market..

Orthofix Medical Inc. (OFIX) Investor Outlook: Exploring a Potential 100% Upside

Orthofix Medical Inc. (NASDAQ: OFIX), a prominent player in the medical devices sector, is garnering increased investor attention due to its promising potential for substantial upside...

Nutex Health Inc. (NUTX) Stock Analysis: Healthcare Innovator with Over 100% Upside Potential

Nutex Health Inc. (NUTX), a dynamic player in the healthcare sector, is attracting significant investor attention with its impressive performance metrics and substantial upside potential. Operating..

Trevi Therapeutics, Inc. (TRVI) Stock Analysis: Potential Upside of 256.68% and Strong Buy Ratings Signal Promising Prospects

Trevi Therapeutics, Inc. (TRVI), a dynamic player in the biotechnology sector, is capturing the attention of investors with its significant potential upside and robust analyst support...

STAAR Surgical Company (STAA) Stock Analysis: Are Analysts Pointing to a 6.94% Upside?

STAAR Surgical Company (NASDAQ: STAA), a key player in the healthcare sector specializing in medical instruments and supplies, has captured the attention of investors with its..

Zymeworks Inc. (ZYME) Stock Analysis: Unpacking a 65.3% Potential Upside in the Biotech Sector

Zymeworks Inc. (NASDAQ: ZYME), a notable player in the biotechnology sector, offers investors a unique proposition with its advanced therapeutic platforms targeting cancer and autoimmune diseases...

Replimune Group, Inc. (REPL) Stock Analysis: Biotechnology Innovator with 132.71% Potential Upside

Investors seeking opportunities in the innovative world of biotechnology should take a closer look at Replimune Group, Inc. (REPL), a clinical-stage biotech firm that is driving..

Collegium Pharmaceutical, Inc. (COLL) Stock Analysis: Uncovering a 35.91% Potential Upside for Investors

Collegium Pharmaceutical, Inc. (NASDAQ: COLL), a prominent player in the specialty pharmaceutical sector, is capturing investor attention with its impressive potential upside of 35.91%. This healthcare..

Stoke Therapeutics (STOK) Stock Analysis: Biotech Innovator with Nearly 95% Upside Potential

Investors keen on the biotechnology sector should keep a watchful eye on Stoke Therapeutics, Inc. (NASDAQ: STOK), a burgeoning player in genetic disease treatment. Positioned in..

Pharvaris N.V. (PHVS) Stock Analysis: Exploring an 85% Potential Upside in Biotech

Pharvaris N.V. (PHVS), a promising player in the biotechnology sector, is drawing significant attention from investors looking for high-growth opportunities. Headquartered in Zug, Switzerland, Pharvaris is..

iRadimed Corporation (IRMD) Stock Analysis: Discovering a 14.89% Potential Upside in the Medical Device Market

iRadimed Corporation (NASDAQ: IRMD), a key player in the healthcare sector, is attracting investor attention with its specialized focus on MRI-compatible medical devices. Headquartered in Winter..

Maravai LifeSciences Holdings (MRVI) Stock Analysis: Exploring an 89.61% Potential Upside in the Biotech Sector

Maravai LifeSciences Holdings, Inc. (NASDAQ: MRVI), a key player in the biotechnology sector, is currently drawing considerable attention from investors, thanks to its substantial potential upside..

Xencor, Inc. (XNCR) Stock Analysis: Exploring a Potential 234.92% Upside in Biotechnology

Xencor, Inc. (NASDAQ: XNCR), a dynamic player in the biotechnology sector, has caught the attention of investors with its innovative focus on monoclonal antibody engineering. With..

CureVac N.V. (CVAC) Stock Analysis: Navigating a 20% Potential Downside Amid Biotech Innovations

CureVac N.V. (NASDAQ: CVAC), a prominent player in the biotechnology sector, is positioning itself as a key innovator with its focus on mRNA-based medicines. Headquartered in..

Talkspace, Inc. (TALK) Stock Analysis: An 80% Potential Upside in the Expanding Virtual Healthcare Market

Investors looking for opportunities in the burgeoning field of digital health services might find Talkspace, Inc. (NASDAQ: TALK) particularly intriguing. The company, which specializes in virtual..

Vir Biotechnology, Inc. (VIR) Stock Analysis: Evaluating a Potential 230% Upside Despite Current Challenges

Vir Biotechnology, Inc. (NASDAQ: VIR) is a clinical-stage biopharmaceutical company that has positioned itself at the forefront of combating infectious diseases, with a rich pipeline that..

US Broker Ratings

US Broker Ratings

FTSE 100

Funds